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PREFACE 
My interest in medication reconciliation was sparked by the interest I developed during 
my endocrine rotation as a registrar in the department of Internal Medicine. Sitting in 
the clinic and consulting numerous patients, the problems with their medication soon 
became apparent. After discussion with my consultants I embarked on this journey to 
see how significant this problem actually was in our clinic. I read extensively around the 
subject and it soon became evident that this study needed to be done in South African 
context. My intention is not to place blame, if any could be attached anywhere, but 
rather to highlight any problem areas where we need improvement in our setting.  
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ABSTRACT 
Background 
Medication reconciliation is the process of creating accurate lists of a patient’s 
medication and comparing them to the treating physician’s script, finding factors that 
influence adherence.   
Objectives 
To determine any discordance between actual medication diabetic hypertensive patients 
at the specialist endocrine outpatient department at CHBH are taking and those on the 
physician’s script, and to determine factors linked to poor adherence.  
Results 
The mean age of the patients was 60 years, and female majority of 73%. Fifty nine 
percent of patients had a maximum of primary school education and 17% had no 
schooling.  
Majority of drugs were taken incorrectly, attributed to stock issues, patient error and use 
of generic medication. Gender, age and whether the doctor routinely tells the patient of 
any adjustments showed no association.  
Conclusion 
Poor adherence was attributed to the patient’s poor knowledge of the medications.  
Adherence to the dosage of drugs was shown to be dependent on a patient’s level of 
education. 
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Chapter 1 Background Literature Review and Critique 
1.1 Hypertension  
1.1.1 Prevalence and complications 
Hypertension is an important worldwide health challenge. Worldwide the prevalence in 
adults aged 20 or more is approximately 26%(1). In sub-Saharan Africa the estimated 
prevalence in 2005 was around 40 million individuals(1). Although accurate measures in 
the South African population is still unknown, increasing urbanization is leading to 
higher rates of hypertension(2). The projection by 2025 is that approximately 75 million 
people in sub-Saharan Africa will have hypertension (2).  
 
Epidemiologic research have established that hypertension is a common and important 
contributor to all of the major cardiovascular diseases, including coronary disease, 
stroke, peripheral artery disease, renal disease, and heart failure(3). Hypertension is 
rarely found in isolation, with more than 80% of hypertensive patients having other risk 
factors for ill health such as glucose intolerance, obesity, left ventricular hypertrophy 
and dyslipidemia(3).  
 
1.1.2. Economic Aspect 
Internationally there is evidence to suggest that good antihypertensive control would 
lead to significant reduction in annual cost of treatment(4, 5). Not only was this true to 
antihypertensive care but also to treatment of other chronic ailments such as diabetes, 
asthma, heart failure, hypercholesterolemia and depression(5).  There are no studies in 
antihypertensive use in sub-Saharan Africa that look at the direct economic benefit of 
good compliance and control of blood pressures. A study by Gaziano et al, showed a 
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possible saving to the economy of approximately $500 million over 10 years, postulated 
on the background change of the current guidelines to treat patients with higher 
cardiovascular risk profiles. There was no reference in this study to note cost benefit 
with current guidelines and better adherence(5).  
 
1.1.3. Background 
About one in four patients do not adhere to prescribed drug therapy(6,14,15). This is 
critical as the consequence of poor adherence has been linked to a negative outcome and 
impacts on overall mortality(6). Not only is this due to primary patient error, but also due 
to system errors within the hospital, such as in prescription and in the dispensing of 
drugs(7). Approximately half of the patients found in the analysis of Coleman et al, 
where categorized as system associated discrepancies leading to poor drug compliance(6, 
8). Thus the problem is a multi-faceted one which requires significant efforts from both 
patient and provider communities.  
 
With the wider development of multiple generic antihypertensive agents many patients 
have been taking the generic as well as the original drug causing further 
complications(9). This has pushed the onus back onto the patient to understand what 
medication they should be taking. Generic equivalent drugs though cheaper, have now 
brought compliance issues significantly back into context(9).  
 
One of the key factors pertaining to compliance is the health literacy of the 
community(10, 11).  Most patients do not know the full range of the drugs that they are 
taking and many of the compliance issues stem back to the consultation itself(9,10,12). 
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Physicians need to take extra time to counsel patients on each new drug, its original and 
generic names, and the side effects of the drugs. It is far too common that physicians do 
not instruct patients properly on how to take medication in a detailed manner(12).   
 
Medication reconciliation is a key process which allows further development into 
strategies to help maintain better levels of compliance in an ambulatory setting(10, 13). It 
is a process that should be applied especially where there are higher rates of perceived 
medical errors and poor patient compliance. 
 
The Chris Hani Baragwanath Academic Hospital (CHBAH) services a large area. The 
specialist endocrine out-patient clinic services approximately 11000 patient visits yearly 
of which a high proportion has hypertension. After doing a thorough literature review, it 
has been documented (mainly in the first world) that there are barriers to compliance in 
patients. The concern for me is how prevalent are the same issues in a South African 
context.  
 
No medication reconciliation has been done previously in South Africa. I aim to 
document the prevalence of medication discrepancies and determine whether health 
literacy plays as important role in compliance.(14-16) 
 
The value of such a study will be to possibly empower patients to further understand 
their illness. It would also possibly serve patients in keeping their same treatments 
irrespective of their changes in medical seeking behaviour. The value to doctors may be 
immense as it may well elucidate underlying problems in compliance and hence 
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treatment failures. The diabetic patient group was chosen as a basis as these patients 
already have a good education level and proven compliance to their insulin regimens.   
 
1.2. Objectives  
i. To determine the level of concordance  between the prescribed medications to the 
actual medications patients are taking at the out-patient department of the 
specialist endocrine and diabetic clinic at CHBAH 
ii. To determine how accurately the patient is following their script 
iii. To determine the relationship between level of education and patient compliance.  
iv. To determine the prevalence of patients overdosing on their antihypertensive 
agents due to concurrent generic and original tablet use. 
 
1.3. Aims 
To determine the level of adherence to antihypertensive medication and to determine 
any barriers to adherence.  
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Chapter 2: Patients and Methods 
  
2.1 Study Design 
The study was a prospective study which involved one on one patient interviews 
combined with medical record abstraction.  
If a patient took at least one or more wrong dosage of a drug, they were classified as 
taking the wrong dosage of drugs. The same applies with the frequency of taking the 
drugs.  
 
2.2 Study Population and Sample 
The study was conducted at the CHBAH. It was done in the endocrine and diabetic out-
patient department. The CHBAH is the largest hospital in the Africa, occupying around 
173 acres. The hospital has approximately 2900 beds. It is situated in the Soweto area of 
Johannesburg. I chose this setting as I am a registrar in Internal Medicine with an 
interest in Endocrinology.  
Medication Reconciliation was performed on the first 100 selected patients meeting the 
inclusion and exclusion criteria by the principle investigator.  
 
2.3 Inclusion and Exclusion Criteria 
Hypertensive diabetic patients on ≥ 2 anti-hypertensive agents and those older than 18 
years old were included, as long as they attended the out-patient Endocrine and diabetic 
clinic at CHBAH. The following was used as exclusion criteria: 
• Patient is not willing to consent to participation in the study;  
• Previously documented poor compliance to clinic follow up. 
 
2.4 Ethical and Legal Consideration 
Ethical clearance was granted by the Human Research Ethics Committee (Appendix A) 
of the University of the Witwatersrand. Permission for the research at CHBAH was 
granted by the CEO and Head of Internal Medicine at CHBAH (clearance certificate no. 
M130833)  
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2.5 Statistical Analysis 
After data collection, the data was captured in excel and later exported to SPSS 
(originally, Statistical Package for the Social Sciences) and now called ‘Statistical 
Product and Service Solutions’ for analysis. SPSS is a computer program which is used 
to carry out a wide variety of statistical analysis easily (25).  
Descriptive statistics such as frequency distributions, cross tabulations, mean and 
standard deviation were used to summarise the data. Chi-square test of association was 
used to assess whether there was any association between categorical variables. In the 
application of the chi-square test, the expected values for each cell should not be less 
than 5. In cases where the sample size is small like in this research resulting in expected 
frequencies of less than 5, the Fisher's Exact Test was used. A Fisher's exact test is very 
useful in analysing contingency tables with both small and large sample. All the chi-
square tests were conducted at 5% significance level(25).  
Pie charts were used to present a pictorial view of the frequencies. A pie chart displays 
data as a percentage of the whole, they are visually appealing but they are best for few 
categories. In cases where there were more categories the bar graphs were used 
especially for prescribed drugs. A histogram was used to illustrate the age distribution 
of the respondents (25).  
Independent sample t-test was used to compare two means of two independent random 
samples. The samples are independent in the sense that they are drawn from different 
populations and each element of one sample is not matched with its corresponding 
element of the other sample. Independent samples t-test was used to compare 
independent samples such as male and female(25).  
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Chapter 3 Results 
3.1 Patient Demographic Information 
3.1.1   Gender 
The sample was made up of 100 patients, 73% of which were females.  
 
3.1.2 Race 
Majority of the patients (90%) were Blacks, 7% were Coloured, 2% Indians and 1% 
White. 
 
3.1.3 Age 
The average age of the patients was 60 years, with the youngest patient being 36 years 
old and the oldest was 81 years old.  
The Histogram below illustrates the age distribution of the patients.  
 
 
Figure 1: Age Distribution 
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3.1.4 Highest level of education 
More than half of the respondents (59%) had primary education as their highest level of 
education, 22% had high school, 2% had university or college education. Seventeen 
percent had no schooling at all.   
 
3.2 Knowledge of anti-hypertensive medication names 
Only 16% of the patients indicated that they knew all their anti-hypertensive 
medications’ names, 83% did not know any anti-hypertensive medication names. 
 
3.3 Treatment dosage knowledge 
As with the anti-hypertensive medications’ names, a very small proportion of the 
patients (10%) knew all anti-hypertensive medication dosages.  
3.4 Doctors communication with patients  
Patients were asked if the doctors and pharmacists routinely told them when doses were 
adjusted or if new tablets were commenced. Almost two thirds of the patients (64%) 
indicated that the doctors and pharmacists do not inform them, 34% confirmed that their 
doctors inform them of changes and the other 2% did not answer the question. 
 
Figure 2: Figure documenting if doctors/pharmacists routinely tell patients when doses 
will be adjusted or if new tablets will commence 
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3.5 Drugs prescribed to patients  
The bar graph below shows the types of drugs prescribed by the doctors. The most 
commonly prescribed drug is Aspirin which was prescribed to 92% of the patients, 
followed by Simvastatin which was prescribed to 80% of the patients. The rest of the 
drugs in descending order of frequency of prescription are shown in table 1. 
 
3.6 Patients Taking Prescribed Dosage or Not 
Table 1: Patients taking prescribed dosage or not 
Drug n Taking Correct Dosage 
Aspirin 92 71% 
Simvastatin 80 70% 
Enalapril 47 87% 
Nifedipine 47 38% 
Hydrochlorothiazide 37 76% 
Indapamide 37 76% 
Amlodopine 33 61% 
Perindopril 33 73% 
Doxazocin 26 73% 
Atenolol 24 79% 
Furosemide 17 94% 
Carvedilol 9 78% 
Spiranolactone 8 75% 
Telmisartan 8 75% 
Verapamil 3 100% 
Atorvastatin 2 50% 
Digoxin 1 100% 
Methyldopa 1 100% 
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3.7 Reasons for not taking the prescribed dosage 
The most common reason for not taking the prescribed dosage is because the prescribed 
drug will be out of stock, followed by patient error and then generic error. 
 
Table 2: Reasons for not taking the prescribed dosage 
  Reasons for not taking the prescribed dosage 
Drug 
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Aspirin 27 85% 11%      
Simvastatin 24 96% 4%      
Enalapril 6 17% 67% 17%     
Nifedipine 29 7%  83% 7%  3%  
Hydrochlorothiazide 9 11% 33%  44% 11%   
Indapamide 9 78% 11% 11%     
Amlodopine 13 38% 15% 38%     
Perindopril 9 11% 33% 44%    11% 
Doxazocin 7 43% 29% 29%     
Atenolol 5 20% 40% 40%     
Furosemide 1  100%      
Carvedilol 2 50% 0% 50%     
Spiranolactone 2 50% 50% 0%     
Telmisartan 2 100%       
Atorvastatin 1 100%       
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3.8 Patients Taking Drugs at the Prescribed Frequency or Not 
Table 3: Frequency of patient taking drug correctly 
Drug n Correct Frequency 
Aspirin 92 71% 
Simvastatin 80 73% 
Enalapril 47 72% 
Nifedipine 47 89% 
Hydrochlorothiazide 37 81% 
Indapamide 37 81% 
Amlodopine 33 82% 
Perindopril 33 91% 
Doxazocin 26 88% 
Atenolol 24 96% 
Furosemide 17 82% 
Carvedilol 9 100% 
Spiranolactone 8 88% 
Telmisartan 8 75% 
Verapamil 3 100% 
Atorvastatin 2 50% 
Digoxin 1 100% 
Methyldopa 1 100% 
 
The most common reason for not taking the drugs at the prescribed frequency is 
because the prescribed drug will be out of stock, followed by patient error and 
pharmacy error. 
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Table 4: Reason for not taking the drugs at prescribed frequency  
 Reason for not taking the drugs at prescribed 
frequency 
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Aspirin 27 85% 7%      
Simvastatin 22 100%       
Enalapril 13 8% 92%      
Nifedipine 5 40%   40%  20%  
Hydrochlorothiazide 7 14% 14%  43% 14%   
Indapamide 7 100%       
Amlodopine 6 83%  17%     
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Perindopril 3 33% 33% 33%    33% 
Doxazocin 3 67%       
Atenolol 1 100%       
Furosemide 3  100%      
Spiranolactone 1 100%       
Telmisartan 2 100%       
Atorvastatin 1 100%       
 
 
3.9 Taking prescribed dosage  
 
More than half of the patients (55%) were taking the wrong dosage for at least one drug 
and the other 45% were taking the correct dosage on all the prescribed drugs. The pie 
chart below shows whether the patients were adhering to the prescribed frequency of 
drug taking.   
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Almost three quarters of the patients (74%) were taking all their drugs at the prescribed 
frequency whilst the other 26% were deviating from the prescribed frequencies. 
3.10 Dosage adherence correlated to gender 
Table 5: Table to show dosage adherence correlation to patient’s gender 
Crosstab 
 Dosage Total 
Wrong Dosage Correct Dosage 
Gender Male Count 10 14 24 
% within 
Gender 
41.7% 58.3% 100.0% 
Female Count 44 29 73 
% within 
Gender 
60.3% 39.7% 100.0% 
Total Count 54 43 97 
% within 
Gender 
55.7% 44.3% 100.0% 
Chi-Square Tests 
 Value df P-Value 
Pearson Chi-Square 2.534a 1 0.111 
N of Valid Cases 97   
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 10.64. 
 
Although there is a slightly higher proportion of women who take the wrong dosage of 
drugs (60.3%) compared to 41.7% for male patients, the difference is not statistically 
significant.  
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3.11 Frequency adherence correlated to gender  
 
Table 6: Table to show frequency adherence correlation to patient’s gender 
Crosstab 
 Frequency Total 
Wrong 
Frequency 
Correct 
Frequency 
Gender Male Count 5 19 24 
% within 
Gender 
20.8% 79.2% 100.0% 
Female Count 20 53 73 
% within 
Gender 
27.4% 72.6% 100.0% 
Total Count 25 72 97 
% within 
Gender 
25.8% 74.2% 100.0% 
Chi-Square Tests 
 Value df P-Value 
Pearson Chi-Square .407a 1 0.524 
N of Valid Cases 97   
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 6.19. 
 
There were no significant difference between male and female patients in terms of 
sticking to the prescribed frequency of taking drugs (p-value = 0.524 > 0.05 the 
significance level). 
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3.12 Dosage adherence correlated to patient’s age  
Table 7: Table to show dosage adherence correlation to patient’s age 
Group Statistics Independent Samples Test 
Dosage n Mean 
Age 
Std. Deviation t P-Value 
Age 
Correct 
Dosage 45 60.42 9.776 0.356 0.723 
Wrong Dosage 55 59.76 8.722 
 
The patients taking the correct dosages on all their medication were on average 60.42 
years old and those taking the at least one dosage wrong were on average 59.76 years 
old. The mean ages were not statistically different (p-value =0.723 > 0.05, the 
significance level). 
 
3.13 Frequency adherence correlated to patient’s age  
Table 8: Table to show frequency adherence correlation to patient’s age 
Group Statistics Independent Samples 
Test 
Frequency n Mean Age Std. 
Deviation 
t P-Value 
Age Correct 
Frequency 74 60.04 9.050 -0.036 0.972 
Wrong Frequency 26 60.12 9.684 
 
The patients taking drugs at the prescribed frequency on all their medication were on 
average 60.04 years old while those taking the at least one of their prescribed drug at a 
wrong frequency were on average 60.12 years old. The mean ages were not statistically 
different (p-value =0.972 > 0.05, the significance level). 
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3.14 Dosage adherence correlated to patient’s level of education 
Table 9: Table to show dosage adherence correlation to patient’s level of education 
 
 Correct Dosage Total 
Wrong 
Dosage 
Correct 
Dosage 
Highest 
Level of 
Education 
No 
schooling 
Count 13 4 17 
% within Highest Level of 
Education 
76.5% 23.5% 100.0% 
Primary 
school 
Count 33 26 59 
% within Highest Level of 
Education 
55.9% 44.1% 100.0% 
High 
School and 
higher 
Count 9 15 24 
% within Highest Level of 
Education 
37.5% 62.5% 100.0% 
Total Count 55 45 100 
% within Highest Level of 
Education 
55.0% 45.0% 100.0% 
Chi-Square Tests 
 Value df P-Value 
Pearson Chi-Square 6.157a 2 .046 
N of Valid Cases 100   
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 7.65. 
 
The patients that do not have any schooling at all had the highest proportion taking 
wrong dosages of drugs (76.5%) compared to 55.9% for the patients with primary 
education and 37.5% for patients with at least high school education. The p-value of the 
Chi-square test is less than 0.05 (p-value = 0.046). It is concluded that there is an 
association between highest level of education and a patient’s ability to take the 
prescribed dosage of a drug. It can be noted that the higher the level of education the 
better the ability to take the correct dosage of drugs. 
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3.15 Frequency adherence correlated to patient’s level of education 
 
 
Table 10: Table to show frequency adherence correlation to patient’s level of education 
 
 Frequency Total 
Wrong  Correct  
Highest 
Level of 
Education 
No 
schooling 
Count 7 10 17 
% within Highest Level of 
Education 
41.2% 58.8% 100.0% 
Primary 
school 
Count 15 44 59 
% within Highest Level of 
Education 
25.4% 74.6% 100.0% 
High 
School and 
higher 
Count 4 20 24 
% within Highest Level of 
Education 
16.7% 83.3% 100.0% 
Total Count 26 74 100 
% within Highest Level of 
Education 
26.0% 74.0% 100.0% 
Chi-Square Tests 
 Value df P-Value Exact Sig. (2-sided) 
Pearson Chi-Square 3.132a 2 .209 .218 
Fisher's Exact Test 3.019   .230 
N of Valid Cases 100    
a. 1 cells (16.7%) have expected count less than 5. The minimum expected count is 4.42. 
The results shows that the there is no association between taking drugs at the prescribed 
frequency and a patient’s highest level of education (p-value of the Fisher's Exact Test 
was greater than 0.05 (p-value = 0.230). The Fisher's Exact Test is used instead of the 
Pearson chi-square because one of the cells in the cross tabulation has an expected value 
less than 5 and thus the normal chi-square will produce biased results. 
 
 
 
 
	   29	  
3.16 Dosage adherence correlated to whether the doctor routinely tells the patient 
if the doses are adjusted 
Table 11: Table to show dosage adherence correlation to whether the doctor routinely 
tells the patient if the doses are adjusted 
 
 Dosage Total 
Wrong  Correct  
Doctors routinely tell 
patients when doses 
will be adjusted or if 
new tablets will 
commence 
Yes Count 15 19 34 
% within Doctors 
routinely tell  
44.1% 55.9% 100.0% 
No Count 39 25 64 
% within Doctors 
routinely tell  
60.9% 39.1% 100.0% 
Total Count 54 44 98 
% within Doctors 
routinely tell  
55.1% 44.9% 100.0% 
Chi-Square Tests 
 Value Df P-Value 
Pearson Chi-Square 2.539a 1 0.111 
N of Valid Cases 98   
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 15.27. 
 
The results reveals that there is no association between taking the correct dosage of 
drugs and whether the doctor routinely tells the patient if the doses are adjusted (p-value 
=0.111> 0.05, the significance level). 
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3.17 Frequency adherence correlated to whether the doctor routinely tells the 
patient if the doses are adjusted 
Table 12: Table to show frequency adherence correlation to whether the doctor 
routinely tells the patient if the doses are adjusted 
 
 Frequency Total 
Wrong 
Frequency 
Correct 
Frequency 
Doctors routinely tell 
patients when doses 
will be adjusted or if 
new tablets will 
commence 
Yes Count 6 28 34 
% within Doctors 
routinely tell  
17.6% 82.4% 100.0% 
No Count 19 45 64 
% within Doctors 
routinely tell 
29.7% 70.3% 100.0% 
Total Count 25 73 98 
% within Doctors 
routinely tell 
25.5% 74.5% 100.0% 
Chi-Square Tests 
 Value df P-Value 
Pearson Chi-Square 1.694a 1 0.193 
N of Valid Cases 98   
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 8.67. 
 
The results reveals that there is no association between taking drugs at the prescribed 
frequency and the doctor routinely telling the patient if the doses or frequency  are 
adjusted or not (p-value =0.193 > 0.05, the significance level). 
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Chapter 4 Discussion  
4.1 Discussion 
The treatment of hypertension is essential to decrease the risk of cardiac failure, 
preserve renal function, decrease incidence of dementia and to prevent blindness in 
diabetic patients(16,17,18). However adherence to treatment has been a major drawback to 
longevity and quality of life (19). Despite effective treatment regimens for the control of 
hypertension poor adherence remains an issue. Anywhere between 20-70 percent non 
adherence to therapy has been documented (20).  
The statistical conclusion showed that the ability to take the prescribed dosage of drugs 
is only dependent on a patient’s highest level of education. Gender, age or whether the 
doctor routinely tells the patient if the doses are adjusted showed no correlation to 
compliance.  
 
Our data concurs with existing literatures that have shown high levels of poor 
compliance. Furthermore our study has aimed to highlight the causative factors for this 
as is highlighted in the discussion below. 
 
The ability to take the prescribed dosage of drugs is dependent on a patient’s highest 
level of education. This was shown in our study where the higher the level of education 
of the patient, the higher the likelihood of adherence. 
 
The ability to take the prescribed dosage  has nothing to do with gender, age and 
whether the doctor routinely tells the patient if the doses are adjusted or not. Our study 
could not show any causal relationship with these variables. 
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There are huge problems with regards to stock levels of medication that accounts for 
poor adherence.  
 
Nifedipine is the most prescribed antihypertensive medication. Overwhelmingly there is 
poor adherence to correct dosage of this drug. The major factor related to the poor 
dosage compliance is different generic suppliers.  
 
An overwhelming concern highlighted in this study is the overdosing of most 
antihypertensive drugs. Furthermore in the groups of drugs where overdosing is 
occurring, it was evident that it is the same group where multiple generics are on tender. 
Nifedipine is the most common example of overdosing of an antihypertensive agent as a 
result of generic use of medication. Due to the various names of this calcium channel 
blocker some patients were taking up to three times the maximum dose. Multiple 
suppliers of generic drugs are leading to worsening adherence with regards to dosage. 
  
There is a lack of effective doctor-patient discussion prior to dose adjustments, although 
this was proven to be statistically insignificant when matched to compliance. Sixty four 
percent of patients in the study believed that doctors and pharmacists are providing 
inadequate explanations to dosage changes on their scripts. The literature has differing 
opinions on this matter with some studies showing relevance to compliance from the 
doctor/pharmacist to patient interaction(23).  
 
Our study found statistically significant rates of poor compliance linked to the level of 
education This may impact the patients understanding and perception of their illness(21). 
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Our patients in this study mainly come from poor socioeconomic backgrounds, poor 
literacy levels and a high level of unemployment, all of which have been mentioned as 
risk factors for poor adherence(22). 
  
Inadequate medication stocks have been shown to further worsen adherence. Due to our 
patient’s background of poverty they are generally unable to afford buying medication 
‘out of pocket’ which leads to further non-compliance. Many medications are out of 
stock at any given time. This shows that there is indeed more than just the doctor-
patient interplay that needs to be addressed. There are inherent problems in the health 
care system at large which need to be addressed, so that adequate levels of stock may 
stop adding to poor adherence.  
 
Multiple generic tablets leads to confusion amongst patients and this contributes to poor 
adherence and the possibility for drug-drug interaction. A high number of generics are 
available for the more widely used medications in the study and wherever generics were 
available patients adherence levels dropped and the errors in their medication 
reconciliation increased. 
 
Our setting is one where the patients are from a disadvantaged background where we 
have shown in this study a high level of poor adherence. We have also shown the large 
number of errors in taking prescribed medications. It becomes imperative for the health 
service providers, i.e. government, doctors and pharmacists to make it as simple as 
possible for patients to improve compliance. My recommendation would be for 
nationwide review of generic suppliers, longer tenders to be granted and maybe force 
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companies tendering to comply with providing drugs in similar packaging of the same 
drugs. Furthermore I would suggest focused groups for patients to learn about their 
treatment and reasons for their medication.  
 
Limitations of this study must be kept in mind when taking the discussion into 
cognisance.  Not all the specific generic medication names were found, as there were 
constantly changing suppliers to the hospitals pharmacy.  The pharmacy could not 
guarantee which tender would provide the drugs to the hospital on a monthly basis. This 
meant a review of the potential generic drugs (by name) was not ascertained in this 
study.  Another limitation is the sample size. 
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4.2 Recommended future research  
The scope of medication reconciliation is vast and the above study does leave room for 
further studies in this field. A thorough interrogation of level of literacy needs to be 
explored in relation to adherence.  Medication reconciliation would be applicable in any 
other speciality to further understand if these problems are not just isolated to this 
department and hospital.  
 I would suggest tracing the causes of poor stock levels of medications. The overall 
number of out of stock medication is concerning for the patients who in the most part do 
not understand their treatment strategies.  
Treatment turbulence is another concept that needs to be addressed in our setting. Our 
patients often see a different physician at every visit and hence variations in 
prescriptions for the patients may exist. This needs to be audited for as a possible cause 
of poor adherence.  
Further issues involving polypharmacy and adverse events in the elderly need to be 
assessed for at our hospital. 
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